PrintyMed
PrivateLast Round
Grant
Apr 28, 2026
Total Funding Raised
$1.62M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
PrintyMed is a biotechnology company that develops biomimetic spider silk materials for use in regenerative medicine and 3D-printed artificial organs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Medical Devices, Fashion & Beauty, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PrintyMed Comparables
Compare PrintyMed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spiber Technologies AB | 84% | |
| Seevix Material Sciences | 80% | |
| Cellbox Labs | 74% |
PrintyMed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 28, 2026 | ||||
| Grant | Mar 5, 2026 | ||||
| Accelerator | Sep 23, 2025 | ||||
| Grant | Oct 8, 2024 | ||||
| Grant | Dec 11, 2023 | ||||
Pre Seed | Aug 28, 2023 |
PrintyMed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Confluence | Accelerator |
| Investment and Development Agency of Latvia | Grant, Accelerator |
| Health Founders | Pre Seed |
| Women TechEU | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 5, 2026
$86K grant received from Women TechEU
- Sep 23, 2025
$6K round from Confluence, Helve, and Investment and Development Agency of Latvia.
PrintyMed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PrintyMed's valuation, stock price, and market status.
Is PrintyMed a public or private company?
PrintyMed is a private company.
What is the current stock price of PrintyMed?
PrintyMed is a private company with no public stock price. No recent secondary market data is available.
How much is PrintyMed worth (valuation)?
Valuation information for PrintyMed is not publicly available.
Can I buy PrintyMed stock?
PrintyMed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was PrintyMed's last funding round?
PrintyMed's most recent funding round was Grant on April 28, 2026.
Who are the main investors in PrintyMed?
Key investors in PrintyMed include European Innovation Council, Confluence, Investment and Development Agency of Latvia, Health Founders, Women TechEU.
Will PrintyMed IPO soon?
No public IPO plans have been announced for PrintyMed.
How can I track PrintyMed secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PrintyMed's secondary market activity and sign up for updates.